NEW YORK — Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs. The technology is expected to be capable of enumerating, screening, and scoring billions of synthetically feasible, virtual compounds supporting the identification and optimization of […]
WEST SACRAMENTO, CA, and COLUMBUS, OH – Gemini Bioproducts, LLC (“Gemini”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Celartia, Inc. Effective immediately, customers can now purchase Celartia’s line of closed, single-use cell […]
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante […]
FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced a distribution partnership with TOMY Digital Biology Co., Ltd., a leading Japanese biotech organization. TOMY provides high-quality instruments and services to industry segments including biotechnology, biological engineering, medical science, and food […]
License agreement expands New England Biolabs’ rights to use and sell CRISPR/Cas9 reagents and tools DUBLIN, Ireland, and Ipswich MA, USA : ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with New England Biolabs (NEB®), […]
Partnership will advance both firms’ positions in the field of molecular dynamics-based drug discovery NEW YORK and SANTA FE, N.M. — Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye’s pioneering Orion computational platform into Redesign’s drug discovery platform. The practice of drug discovery has radically transformed […]
genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system Lyon, France – genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic alliance with Merck, a leading science and technology company and leader in genome editing. In December 2018, genOway […]
Leading local firm driving adoption of biotechnology for yield, safety, and consistency throughout the region BEVERLY, Mass. — Medicinal Genomics Corp. (MGC), a pioneer in genomics and blockchain technology to improve the yield, safety, and transparency of cannabis, today announced its partnership with Analogic Solutions as its distributor of record for the Caribbean region. Analogic is headquartered in Trinidad and […]
Columbus, Ohio and Boston, Massachusetts – CAS, a division of the American Chemical Society, partnered with Scilligence to integrate SciFindern with Scilligence ELN (Electronic Laboratory Notebook). This integration helps scientists simplify their workflow by allowing easy access to vital research information in SciFindern and maintaining traceability of their ideas. Structure and reaction searches in the SciFindern content collection can […]
The Baker Company, global leader in containment technology, owner of Baker Ruskinn, itself a global leader in anaerobic and precision low-oxygen culture solutions for microbiology and cell culture applications, has partnered with Lucid Scientific, to distribute their unique RESIPHER solution that turns a multi-well plate into a dynamic oxygen consumption reader. “We are excited to be working […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
